Buchele, Carolin
Renkamp, C. Katharina
Regnery, Sebastian
Behnisch, Rouven
Rippke, Carolin
Schlüter, Fabian
Hoegen-Saßmannshausen, Philipp
Debus, Jürgen
Hörner-Rieber, Juliane
Alber, Markus
Klüter, Sebastian
Funding for this research was provided by:
Medizinische Fakultät Heidelberg der Universität Heidelberg
Article History
Received: 26 March 2024
Accepted: 10 June 2024
First Online: 25 June 2024
Declarations
:
: This study was approved by the local ethics board (Ethikkommission der Medizinischen Fakultät Heidelberg, S-479/2021) and was conducted according to the declaration of Helsinki. Written consent was not required for this retrospective study.
: Not applicable.
: J. H.-R. and S. K. received speaker fees from ViewRay Inc outside the submitted work. J. H.-R. received speaker fees from Pfizer Inc., Astra Zeneca and Sanofi as well as travel reimbursement from ViewRay Inc. and research grants from IntraOP Medical and Varian Medical Systems outside the submitted work. P. H.-S. received fees from NovoCure GmbH outside the submitted work. J.D. received grants from Accuray International Sàrl, Merck Serono GmbH CRI – The Clinical Research Institute GmbH, View Ray Inc., Accuray Incorporated, RaySearch Laboratories AB, Vision RT limited, Astellas Pharma GmbH, Astra Zeneca GmbH, Solution Akademie GmbH, Ergomed PLC Surrey Research Park, Siemens Healthcare GmbH, Quintiles GmbH, Pharmaceutecal Research Associates GmbH, Boehringer Ingelheim Pharma GmbH Co, PTW-Freiburg Dr. Pychlau GmbH, Nanobiotix A.A. and IntraOP Medical, all outside the submitted work.